Tachon et al reported a case that exhibited heterogeneous expression of MLH1 and PMS2 and had both MSI and MSS tumor areas.23 Therefore, multiple zone analyses, involving both MMR IHC and MSI detection, should be performed to better assess dMMR/MSI status. The gene discussed is MLH1; the disease is neoplasm.